BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16611324)

  • 1. Transplant tolerance in non-human primates: progress, current challenges and unmet needs.
    Kean LS; Gangappa S; Pearson TC; Larsen CP
    Am J Transplant; 2006 May; 6(5 Pt 1):884-93. PubMed ID: 16611324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primate models in organ transplantation.
    Anderson DJ; Kirk AD
    Cold Spring Harb Perspect Med; 2013 Sep; 3(9):a015503. PubMed ID: 24003248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplant Tolerance: Current Insights and Strategies for Long-Term Survival of Xenografts.
    Liu L; He C; Liu J; Lv Z; Wang G; Gao H; Dai Y; Cooper DKC; Cai Z; Mou L
    Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):355-364. PubMed ID: 29992337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism.
    Kawai T; Cosimi AB; Sachs DH
    Curr Opin Organ Transplant; 2011 Aug; 16(4):366-71. PubMed ID: 21666482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonhuman primate models of transplant tolerance: closer to the holy grail.
    Kitchens WH; Adams AB
    Curr Opin Organ Transplant; 2016 Feb; 21(1):59-65. PubMed ID: 26709576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed chimerism through donor bone marrow transplantation: a tolerogenic cell therapy for application in organ transplantation.
    Pilat N; Hock K; Wekerle T
    Curr Opin Organ Transplant; 2012 Feb; 17(1):63-70. PubMed ID: 22186093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-bone Bone Marrow Transplantation in Pig-to-Nonhuman Primates for the Induction of Tolerance Across Xenogeneic Barriers.
    Yamada K; Ariyoshi Y; Pomposelli T; Takeuchi K
    Methods Mol Biol; 2020; 2110():213-225. PubMed ID: 32002911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
    Cosimi AB; Sachs DH; Sykes M; Kawai T
    Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation.
    Kean LS; Durham MM; Adams AB; Hsu LL; Perry JR; Dillehay D; Pearson TC; Waller EK; Larsen CP; Archer DR
    Blood; 2002 Mar; 99(5):1840-9. PubMed ID: 11861303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitating cells as a venue to establish mixed chimerism and tolerance.
    Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
    Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.
    Zheng HB; Watkins B; Tkachev V; Yu S; Tran D; Furlan S; Zeleski K; Singh K; Hamby K; Hotchkiss C; Lane J; Gumber S; Adams AB; Cendales L; Kirk AD; Kaur A; Blazar BR; Larsen CP; Kean LS
    Am J Transplant; 2017 Mar; 17(3):657-670. PubMed ID: 27500470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with immunotoxin.
    Knechtle SJ
    Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosenescence does not abrogate engraftment of murine allogeneic bone marrow.
    Hock K; Oberhuber R; Lee YL; Wrba F; Wekerle T; Tullius SG
    Transplantation; 2013 Jun; 95(12):1431-8. PubMed ID: 23694950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance through bone marrow transplantation with costimulation blockade.
    Wekerle T; Blaha P; Langer F; Schmid M; Muehlbacher F
    Transpl Immunol; 2002 May; 9(2-4):125-33. PubMed ID: 12180819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching.
    Larsen CP; Page A; Linzie KH; Russell M; Deane T; Stempora L; Strobert E; Penedo MC; Ward T; Wiseman R; O'Connor D; Miller W; Sen S; Singh K; Kean LS
    Am J Transplant; 2010 Nov; 10(11):2396-409. PubMed ID: 20849552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge about transplantation tolerance gained in primates.
    Knechtle SJ
    Curr Opin Immunol; 2000 Oct; 12(5):552-6. PubMed ID: 11007358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of tolerogenic strategies in the clinic.
    Knechtle SJ
    Philos Trans R Soc Lond B Biol Sci; 2005 Sep; 360(1461):1739-46. PubMed ID: 16147538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates.
    Yamada Y; Boskovic S; Aoyama A; Murakami T; Putheti P; Smith RN; Ochiai T; Nadazdin O; Koyama I; Boenisch O; Najafian N; Bhasin MK; Colvin RB; Madsen JC; Strom TB; Sachs DH; Benichou G; Cosimi AB; Kawai T
    Am J Transplant; 2012 Feb; 12(2):330-40. PubMed ID: 22053723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.